ReviewActa biomaterialia2021

Designing biomaterials for the modulation of allogeneic and autoimmune responses to cellular implants in Type 1 Diabetes.

Magdalena M Samojlik et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.